BrainsWay Ltd. said Evernorth Behavioral Health, a division of the Cigna Group serving more than 18 million covered lives across 12 states, will eliminate prior authorization requirements for transcranial magnetic stimulation (TMS) for contracted providers treating patients covered under Evernorth and Cigna Healthcare plans. BrainsWay said Evernorth’s change is effective March 6, 2026. The company added that Evernorth currently covers TMS for major depressive disorder in adolescents and adults and for obsessive-compulsive disorder.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brainsway Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602180730PRIMZONEFULLFEED9655655) on February 18, 2026, and is solely responsible for the information contained therein.
Comments